AG
EVH icon

AlphaSimPlex Group’s Evolent Health EVH Stock Holding History

AlphaSimPlex Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,709
Closed -$332K – 162
2021
Q3 		$332K Sell
10,709
-19,469
-65% -$467K 0.27% 160
2021
Q2 		$637K Hold
30,178
– – 0.32% 140
2021
Q1 		$610K Sell
30,178
-5,357
-15% -$102K 0.26% 175
2020
Q4 		$570K Buy
+35,535
New +$470K 0.2% 220

Other funds holding EVH

EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

AlphaSimPlex Group's EVH Position: Q4 2021 in Review

AlphaSimPlex Group sold out of Evolent Health (EVH) in Q4 2021, closing a stake of 10,709 shares — an estimated $332K sold.

AlphaSimPlex Group first reported a position in EVH in Q4 2020 and held it in 4 quarters. The position peaked at $637K in Q2 2021. 207 funds tracked by Wall St. Rank hold EVH as of Q4 2021.

  • AlphaSimPlex Group reported no remaining Evolent Health position as of Q4 2021 after selling out during the quarter.
  • AlphaSimPlex Group sold 10,709 Evolent Health shares in Q4 2021, an estimated $332K.
  • AlphaSimPlex Group first reported a position in Evolent Health in Q4 2020 and held it in 4 quarters.
  • AlphaSimPlex Group's Evolent Health position peaked at $637K in Q2 2021.
  • 207 funds tracked by Wall St. Rank held Evolent Health as of Q4 2021.

Based on AlphaSimPlex Group's 13F filing for Q4 2021, filed 10 Feb 2022.